STERIS plc STE

NYSE · Healthcare · Medical - Specialties

$255.76

Close on Fri, 20 Nov 2026 · market value $24.8B

What the price is betting on

Priced for a lot to go right

At $256, the price assumes revenue grows about 9.8% a year for five years, from $6.2B to about $9.4B by FY2031. That is about one and a half times what analysts expect for the next two years and about one and a half times the company's own last three years.

The price assumes9.8%
Analysts, next two years6.6%
Last 3 years7.6%

Revenue growth a year. The price figure comes from a reverse DCF at a 8.6% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than STE? Check up to 5 of your stocks at once, free, no account.

0$2.5B$5B$7.5B$10B$6.2B'23'24'25'26Sep '26'27'28'29'30'31What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$186

Base

$215

Bull

$249

Today $256

  • Bear $186. Cash flow grows 4% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $215. Cash flow grows 7% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $249. Cash flow grows 9% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2027$6.5B$6.4B, on the path
  3. FY2028$7.1B$6.8B, below the path
  4. FY2029$7.8B$7.2B, below the path
  5. FY2030$8.5B$8B, below the path
  6. FY2031$9.4BThe full bet

Each year's revenue at 9.8% growth from $6.2B in the 12 months to September 2026.

At a glance

Healthcare · Medical - Specialties · listed on NYSE

Revenue, FY2026
$5.9B
Growth, 3 years a year
7.6%
Cash margin
16%
Net debt
$1.6B
Shares, 3-year change
−1.5%
Dividend yield
1%

What other healthcare prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.